- £727.45m
- £1.01bn
- £647.30m
- 75
- 23
- 70
- 58
Annual income statement for CVS, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | R2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 428 | 510 | 554 | 589 | 647 |
| Cost of Revenue | |||||
| Gross Profit | 170 | 222 | 239 | 258 | 278 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 409 | 470 | 511 | 521 | 597 |
| Operating Profit | 18.5 | 40.1 | 42.8 | 68.4 | 50.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 9.9 | 33.1 | 36 | 60.7 | 38.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 5.7 | 19.3 | 25.7 | 48.1 | 26.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 5.7 | 19.3 | 25.7 | 41.9 | 6.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 5.7 | 19.3 | 25.7 | 41.9 | 6.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.125 | 0.273 | 0.48 | 0.718 | 0.505 |
| Dividends per Share |